Add to ORKGApraclonidine is an adrenergic agonist with stronger affinity for α2 receptors than α1 receptors. Following sympathetic denervation in Horner syndrome, α receptors are upregulated, and therefore apraclonidine causes both mydriasis, via the effect of α1 stimulation of the dilator pupillae, and lid elevation, via the effect of α2 stimulation on Müller's muscle. In addition to being helpful in confirming Horner syndrome, apraclonidine can be used as a therapeutic agent for ptosis
Horner syndrome occurs as a result of a lesion along the oculosympathetic pathway. It has numerous p...
Study of adrenergic mydriasis in Horner's syndrome.Thompson, H.S. and Mensher, J.H. (1971). 'Adrener...
Aims: To evaluate the sensitivity and specificity of 0.5% apraclonidine test in the diagnosis of ocu...
The use of apraclonidine is increasing in the pharmacological confirmation of Horner syndrome. The d...
This patient experienced relatively abrupt ptosis and was seen and diagnosed with a Horner's syndrom...
Pharmacological testing with apraclonidine eye drops aids the diagnosis of Horner syndrome by induci...
Horner syndrome is typically described by the classic triad of blepharoptosis, miosis, and anhydrosi...
Apraclonidine hydrochloride is a potent and relatively selective alpha2-adrenergic receptor agonist....
Purpose Used in the diagnosis of Horner's syndrome, apraclonidine 1% dilatates the involved eye due ...
The diagnosis of Horner syndrome (HS) using apraclonidine eye drops is an alternative to the use of ...
Horner syndrome is characterized by miosis and ptosis associated with ipsilateral injury to the symp...
We present a seven-month-old baby with miosis of the left pupil, left hypochromia, mild ipsilateral ...
For more than three decades, topical cocaine has been used to confirm the diagnosis and hydroxyamphe...
Pharmacological testing with apraclonidine eye drops induces a typical reversal of anisocoria in pat...
Horner syndrome is characterized by the presence of a lesion at any location along the oculosympathe...
Horner syndrome occurs as a result of a lesion along the oculosympathetic pathway. It has numerous p...
Study of adrenergic mydriasis in Horner's syndrome.Thompson, H.S. and Mensher, J.H. (1971). 'Adrener...
Aims: To evaluate the sensitivity and specificity of 0.5% apraclonidine test in the diagnosis of ocu...
The use of apraclonidine is increasing in the pharmacological confirmation of Horner syndrome. The d...
This patient experienced relatively abrupt ptosis and was seen and diagnosed with a Horner's syndrom...
Pharmacological testing with apraclonidine eye drops aids the diagnosis of Horner syndrome by induci...
Horner syndrome is typically described by the classic triad of blepharoptosis, miosis, and anhydrosi...
Apraclonidine hydrochloride is a potent and relatively selective alpha2-adrenergic receptor agonist....
Purpose Used in the diagnosis of Horner's syndrome, apraclonidine 1% dilatates the involved eye due ...
The diagnosis of Horner syndrome (HS) using apraclonidine eye drops is an alternative to the use of ...
Horner syndrome is characterized by miosis and ptosis associated with ipsilateral injury to the symp...
We present a seven-month-old baby with miosis of the left pupil, left hypochromia, mild ipsilateral ...
For more than three decades, topical cocaine has been used to confirm the diagnosis and hydroxyamphe...
Pharmacological testing with apraclonidine eye drops induces a typical reversal of anisocoria in pat...
Horner syndrome is characterized by the presence of a lesion at any location along the oculosympathe...
Horner syndrome occurs as a result of a lesion along the oculosympathetic pathway. It has numerous p...
Study of adrenergic mydriasis in Horner's syndrome.Thompson, H.S. and Mensher, J.H. (1971). 'Adrener...
Aims: To evaluate the sensitivity and specificity of 0.5% apraclonidine test in the diagnosis of ocu...